title: [Subcutaneous administration of MabThera for therapy of non-Hodgkin lymphomas frees patients and medical personnel].
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000451:nursing; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000451:nursing; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000451:nursing*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab